Bronchiectasis
Bronchiectasis is characterized by irreversible anatomical abnormalities of local bronchi. It is caused by chronic suppurative inflammation and fibrosis of the bronchi and surrounding lung tissues, which destroy the muscle and elastic tissue of the bronchial wall, leading to bronchial deformation and persistent dilation. Typical clinical symptoms include chronic cough, coughing up large amounts of purulent sputum, and repeated hemoptysis. The main pathogenic factors are bronchial infection, obstruction, and traction, and some are congenital genetic factors. Most patients have a history of childhood measles, whooping cough, or bronchopneumonia. With the improvement of people's lives, vaccination against measles and whooping cough, and the use of antibiotics, this disease has been significantly reduced.
Related Drugs
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:
Luan Worldbest Pharmaceuticals Co., Ltd.
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:
Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:
Lanxiha Sanlian Pharmaceutical Co., Ltd.
Cefuroxime Sodium for Injection
Indication: Used for the following diseases caused by sensitive bacteria: 1. Respiratory tract infections: acute and chronic bronchitis, infectious bronchiectasis, bacterial pneumonia, lung abscess and postoperative chest infection. 2. Ear, nose and throat infections: sinusitis, tonsillitis, pharyngitis. 3. Urinary tract infections: acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. 4. Skin and soft tissue infections: cellulitis, erysipelas, peritonitis and traumatic infection. 5. Bone and joint infections: osteomyelitis and septic arthritis. 6. Obstetric and gynecological infections: pelvic inflammatory disease. 7. Gonorrhea: especially suitable for those who are not suitable for penicillin treatment. 8. Other infections: including sepsis and meningitis; abdominal pelvic and orthopedic surgery; heart, lung, esophageal and vascular surgery; prevention of infection during total joint replacement surgery.
Manufacturer:
Hainan Hailing Chemipharma Corporation Ltd.
Cefuroxime Sodium for Injection
Indication: Used for the following diseases caused by sensitive bacteria: 1. Respiratory tract infections: acute and chronic bronchitis, infectious bronchiectasis, bacterial pneumonia, lung abscess and postoperative chest infection. 2. Ear, nose and throat infections: sinusitis, tonsillitis, pharyngitis. 3. Urinary tract infections: acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. 4. Skin and soft tissue infections: cellulitis, erysipelas, peritonitis and traumatic infection. 5. Bone and joint infections: osteomyelitis and septic arthritis. 6. Obstetric and gynecological infections: pelvic inflammatory disease. 7. Gonorrhea: especially suitable for those who are not suitable for penicillin treatment. 8. Other infections: including sepsis and meningitis; abdominal pelvic and orthopedic surgery; heart, lung, esophageal and vascular surgery; prevention of infection during total joint replacement surgery.
Manufacturer:
Hainan Hailing Chemipharma Corporation Ltd.
Cefuroxime Sodium for Injection
Indication: Used for the following diseases caused by sensitive bacteria: 1. Respiratory tract infections: acute and chronic bronchitis, infectious bronchiectasis, bacterial pneumonia, lung abscess and postoperative chest infection. 2. Ear, nose and throat infections: sinusitis, tonsillitis, pharyngitis. 3. Urinary tract infections: acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. 4. Skin and soft tissue infections: cellulitis, erysipelas, peritonitis and traumatic infection. 5. Bone and joint infections: osteomyelitis and septic arthritis. 6. Obstetric and gynecological infections: pelvic inflammatory disease. 7. Gonorrhea: especially suitable for those who are not suitable for penicillin treatment. 8. Other infections: including sepsis and meningitis; abdominal pelvic and orthopedic surgery; heart, lung, esophageal and vascular surgery; prevention of infection during total joint replacement surgery.
Manufacturer:
Reyoung Pharmaceutical Co., Ltd.